US-Listed Pharmaceutical Preparations — EBITDA Margin Percentiles, FY 2021

Population: 185 US-listed companies (SIC 2834), fiscal year 2021; fiscal year ends 2021-06-30 to 2022-05-29.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile	-531.7%
25th percentile	-328.5%
Median	-92.5%
75th percentile	7.6%
90th percentile	28.7%
Mean	-187.4%
Minimum	-999.7%
Maximum	99.3%

Methodology & sources
EBITDA margin = (operating income + depreciation & amortization) / revenue, all values as filed; computed in SQL per company, then percentiles. Fiscal year 2021 = fiscal years ending 2021-06-01 to 2022-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest EBITDA Margin percentiles (live) · All Pharmaceutical Preparations benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2834/ebitda-margin/2021